Golimumab study for development of tight control and biologics-free condition.
Not Applicable
- Conditions
- rheumatoid arthritis
- Registration Number
- JPRN-UMIN000014485
- Lead Sponsor
- Rheumatology, Internal MedicineJuntendo University School of Medicine, Juntendo Koshigaya Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1.Patients who have history of allergy for golimumab. 2.Patients who have sepsis, severe infection,active tuberculosin infection, congestive heart disease, active B type viral hepatitis,nontuberculous mycobacterial infection, malignant disorders. 3.Patients who are not adequate for this study judged by investigator of this study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.Nubmer of patients who are in the low disease activity at 52 weeks. 2.Number of golimumab-free patients who are in the low disease activity after at 52 weeks.
- Secondary Outcome Measures
Name Time Method